The Trump administration is considering a reduction in the length of time that biologic drugs would be protected from generic imitators, in a bid to win Democratic support for a new trade pact with Mexico and Canada
Many Democrats, backed by labor unions and consumer groups, are pushing the administration to reduce the length of time that leading biologic drugs would be protected from generic imitators in the U.S.
-Mexico-Canada Agreement, or USMCA.México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
U.S. considers easing drug protection to break deadlock over trade pact: Wall Street JournalThe Trump administration is considering scaling back intellectual-property prote...
Leer más »
U.S. considers easing drug protection to break deadlock over trade pact: Wall Street JournalThe Trump administration is considering scaling back intellectual-property prote...
Leer más »
Pelosi to climate conference: 'We're still in' Paris agreementPresident Trump made his decision official last month to withdraw the U.S. from the Paris climate pact, but House Speaker Nancy Pelsoi says 'The United States is still in'
Leer más »
Treasury yields move higher ahead of auctionsU.S. government debt prices were lower Monday morning as traders monitored U.S.-China trade talks.
Leer más »
Many firms have no contingency plans should U.S.-China trade war worsen: DHL surveyAs the U.S.-China trade war drags into its 16th month and continues to disrupt s...
Leer más »
U.S. says sees no reason to reduce tariffs in EU aircraft subsidy caseThe U.S. Trade Representative's office on Monday said it saw no basis in Mo...
Leer más »